Published in Am J Pharm Educ on February 12, 2013
Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy (2014) 0.96
Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics (2013) 0.89
A pharmacogenetics service experience for pharmacy students, residents, and fellows. Am J Pharm Educ (2013) 0.86
Advancing Pharmacogenomics Education in the Core PharmD Curriculum through Student Personal Genomic Testing. Am J Pharm Educ (2016) 0.80
Effects of Using Personal Genotype Data on Student Learning and Attitudes in a Pharmacogenomics Course. Am J Pharm Educ (2016) 0.79
Challenges to integrating pharmacogenetic testing into medication therapy management. J Manag Care Spec Pharm (2015) 0.77
Pharmacogenomics competencies in pharmacy practice: A blueprint for change. J Am Pharm Assoc (2003) (2016) 0.75
Pharmacogenomics in cardiology--genetics and drug response: 10 years of progress. Future Cardiol (2015) 0.75
An inter-professional approach to personalized medicine education: one institution's experience. Per Med (2015) 0.75
Implementation of inpatient models of pharmacogenetics programs. Am J Health Syst Pharm (2016) 0.75
Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Eur J Clin Pharmacol (2017) 0.75
Knowledge, Attitude, and Perceptions of Pharmacists and Pharmacy Students towards Pharmacogenomics in Zimbabwe. Pharmacy (Basel) (2017) 0.75
Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Pharmacogenet Genomics (2017) 0.75
Development and Initial Assessment of a Patient Education Video about Pharmacogenetics. J Pers Med (2017) 0.75
Pharmacogenomics--drug disposition, drug targets, and side effects. N Engl J Med (2003) 7.23
Genomics and drug response. N Engl J Med (2011) 4.35
An active-learning strategies primer for achieving ability-based educational outcomes. Am J Pharm Educ (2011) 3.31
Retention of compounding skills among pharmacy students. Am J Pharm Educ (2006) 2.35
A high-fidelity simulation mannequin to introduce pharmacy students to advanced cardiovascular life support. Am J Pharm Educ (2010) 2.15
Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J Thromb Thrombolysis (2007) 2.12
Realizing the promise of genomics in biomedical research. JAMA (2005) 1.92
Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm (2011) 1.85
Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet (2001) 1.64
Emergence and evolution of pharmacogenetics and pharmacogenomics in clinical pharmacy over the past 40 years. Ann Pharmacother (2007) 1.62
Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ (2011) 1.62
Pharmacogenomics: bridging the gap between science and practice. J Am Pharm Assoc (2003) (2010) 1.04
Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc (2003) (2008) 0.98
Pharmacy students' retention of knowledge and skills following training in automated external defibrillator use. Am J Pharm Educ (2010) 0.96
Learning outcomes and behavioral changes with a pharmacy continuing professional education program. Am J Pharm Educ (2006) 0.94
Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm (2009) 0.93
Integrating pharmacogenomics into pharmacy practice via medication therapy management. J Am Pharm Assoc (2003) (2011) 0.93
Short- and long-term retention of a nursing home education program on metered-dose inhaler technique. Ann Pharmacother (1992) 0.81
Pharmacogenomics: implications and considerations for pharmacists. Pharmacogenomics (2003) 0.79
Considerations on safety concerns about citalopram prescribing. Mayo Clin Proc (2012) 1.97
Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ (2011) 1.62
Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. Crit Care Med (2006) 1.49
Hypovitaminosis D in psychiatric inpatients: clinical correlation with depressive symptoms, cognitive impairment, and prescribing practices. Psychosomatics (2012) 1.41
Acute kidney injury following total joint arthroplasty: retrospective analysis. Can J Anaesth (2012) 1.09
Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia. J Appl Physiol (1985) (2006) 1.06
Hospital rules-based system: the next generation of medical informatics for patient safety. Am J Health Syst Pharm (2005) 1.03
Aging enhances autonomic support of blood pressure in women. Hypertension (2013) 1.01
Influences of adenosine receptor antagonism on vasodilator responses to adenosine and exercise in adenosine responders and nonresponders. J Appl Physiol (1985) (2006) 1.00
Cyclooxygenase inhibition abolishes age-related differences in cerebral vasodilator responses to hypercapnia. J Appl Physiol (1985) (2012) 0.94
Alternative to ganglionic blockade with anticholinergic and alpha-2 receptor agents. Clin Auton Res (2006) 0.87
beta2-Adrenoceptor gene variation and systemic vasodilatation during ganglionic blockade. J Physiol (2010) 0.86
Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study. Mayo Clin Proc (2009) 0.84
A case of venlafaxine-induced galactorrhea? J Clin Psychopharmacol (2008) 0.84
Sex differences in salt sensitivity to nitric oxide dependent vasodilation in healthy young adults. J Appl Physiol (1985) (2011) 0.83
Effectiveness of a computerized system for intravenous heparin administration: using information technology to improve patient care and patient safety. Am Heart Hosp J (2005) 0.83
Cyclooxygenase inhibition augments central blood pressure and aortic wave reflection in aging humans. Am J Physiol Heart Circ Physiol (2012) 0.82
Predictors of prolonged vasopressin infusion for the treatment of septic shock. J Crit Care (2012) 0.81
Inability to ventilate while using a silicone-based endotracheal tube. J Clin Anesth (2008) 0.81
The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole. Am J Hematol (2013) 0.81
Adenosine transporter antagonism in humans augments vasodilator responsiveness to adenosine, but not exercise, in both adenosine responders and non-responders. J Physiol (2006) 0.81
Electrolyte orders in the neuroscience intensive care unit: worth the value or waste? Neurocrit Care (2011) 0.80
The function of vascular smooth muscle phosphodiesterase III is preserved in healthy human aging. Clin Transl Sci (2010) 0.79
Linezolid desensitization for a patient with multiple medication hypersensitivity reactions. Ann Pharmacother (2013) 0.79
Implications of pharmacogenomics for anesthesia providers. AANA J (2010) 0.79
A Clinic Model: Post-Intensive Care Syndrome and Post-Intensive Care Syndrome-Family. AACN Adv Crit Care (2016) 0.76
Intravenous metoprolol versus diltiazem for rate control in noncardiac, nonthoracic postoperative atrial fibrillation. Ann Pharmacother (2014) 0.76
Medication Management to Ameliorate Post-Intensive Care Syndrome. AACN Adv Crit Care (2016) 0.76
In reply. Mayo Clin Proc (2013) 0.75
Benzodiazepine-associated delirium dosing strategy or cumulative dose? Intensive Care Med (2015) 0.75
Cyclo-oxygenase-2 inhibition and endothelium-dependent vasodilation in younger vs. older healthy adults. Br J Clin Pharmacol (2014) 0.75
Risk factors for excessive anticoagulation among hospitalized adults receiving warfarin therapy using a pharmacist-managed dosing protocol. Pharmacotherapy (2013) 0.75
Serum Triamcinolone Levels Following Interlaminar Epidural Injection. Reg Anesth Pain Med (2015) 0.75
Acute dystonia associated with paliperidone overdose. Psychosomatics (2011) 0.75